United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83209-303_438f5c4d-a00a-b851-e063-6394a90a084a
- Product NDC
- 83209-303
- Form
- TABLET
- Composition / generic term
- Buspirone Hydrochloride
- Labeler
- Boswell Pharmacy Services LLC d/b/a BPS Wholesale
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251113
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BLISTER PACK (83209-303-15) · 83209-303-15
- 20 TABLET in 1 BLISTER PACK (83209-303-20) · 83209-303-20
- 30 TABLET in 1 BLISTER PACK (83209-303-30) · 83209-303-30
- 60 TABLET in 1 BLISTER PACK (83209-303-60) · 83209-303-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →